[ad_1]
The lowest price for the vaccine was about $ 4 per dose (Getty).
Global pharmaceutical companies and renowned research centers have entered a race against time since the outbreak of the new Corona virus to produce an effective and reliable vaccine to stop the outbreak of the virus that hit the world economy and triggered a health crisis without precedents.
Dozens of companies and research centers in various countries around the world have announced so far that they are close to producing a vaccine, few of which have actually reached the third stage of trials, which then give them the go-ahead for approval by responsible authorities in the countries.
The World Health Organization said in a previous report that “the goal is for each country to be able to vaccinate 20% of its population by the end of 2021”, which means that the world needs approximately 3 billion doses for approximately 1, 5 billion people in 2021.
Currently, the world is first concerned about the presence of a vaccine that will help slow the spread of the virus and return the global economy to recovery after the unprecedented recession caused by the closures and the repercussions of the virus, but at the same time does not ignore the effectiveness of the virus and the expected price.
Rich countries may not encounter a crisis in purchasing the virus, whatever the price offered, but the greatest crisis will be faced by poor countries, whose price will often be a deciding factor in their decision to buy the vaccine, and its ability thereafter to distribute it for free or at low cost to the population.
In a recent report, Human Rights Watch said that the price of the vaccine can be a major obstacle to obtaining it comprehensively and fairly, and called on governments to force companies to adopt transparent prices that are verified through an audit. from third parties.
Due to global anticipation of the vaccine, some pharmaceutical companies, according to the British Guardian newspaper, expect the market size for Corona vaccine to reach about $ 25 billion annually.
The number is largely related to the stability, diffusion and diversification of the price of vaccines, and not in their early stages, which will witness global competition to acquire the first doses of it.
According to Morgan Stanley, the annual vaccination of the most needy in the world, for vaccine prices that range between 3 and 37 dollars per dose, will generate income of 10 billion dollars annually for the pharmaceutical industry of the United States, Europe and other countries. developed only.
The lowest price for the Corona vaccine, expected so far, is around $ 4 per dose and is for Oxford University, while the highest is for Moderna, with an expected price of $ 37.
The rich obsess
The rich countries have so far contracted most of the vaccines expected to be produced, especially from Moderna and Pfizer, while the rest of the countries have contracted Russian and Chinese companies.
According to pre-purchase agreements signed with Pfizer, there are 1.1 billion doses bought by rich countries, out of a total of 1.3 billion doses expected to be produced by the end of next year, as the United States alone requested some 600 million doses from the company, and the European Union announced the purchase of around 300 million doses of the vaccine “Pfizer” and “Biontech”, without announcing the value of the deal, and the two companies said that deliveries are expected to begin by the end of this year.
The UK previously announced that it had reserved 40 million doses of the Pfizer vaccine, of which 10 million doses could be available before the end of this year, while Israeli Prime Minister Benjamin Netanyahu announced that he had signed an agreement with Pfizer to buy 8 million vaccines.
Moderna, which received $ 2.5 billion from the US government, promised to provide 100 million doses for Americans, including 15 million before the end of December.
Moderna has signed contracts with Canada, Switzerland, Qatar, Japan and Israel and is negotiating with the European Union, Great Britain and the Kovacs International Program.
Moderna aims to produce 20 million doses this year and between 500 million and 1 billion in 2021 thanks to production plants and industrial partners in the United States, Switzerland and Spain.
While the Chinese group “Sinopharma” promised to supply Indonesia with 40 million doses of the same “Corona Vaccine” vaccine by March 2021, while Brazil, one of the countries most affected by the coronavirus, also agreed to buy 46 million doses. of the Chinese vaccine.
The executive director of the Russian Fund for Direct Investment, Kirill Dmitriev, previously said that Russia had received requests from 20 countries to supply it with two billion doses of the “Sputnik V” vaccine.
The Russian newspaper “Kommersant” previously reported that a medical center, which is the largest in Israel, had requested the purchase of 1.5 million doses of the vaccine.
Vaccine prices
Fertilization of the mother: The American company Moderna announced that its experimental vaccine for Covid-19 is 94.5 percent effective in preventing disease, and the vaccine is administered in two doses four weeks apart. It must be transferred to a temperature of minus 20 degrees Celsius, and then stored in the refrigerator (2 to 8 degrees Celsius) for 30 days.
Last August, the company said the dose of its experimental coronavirus vaccine was priced between $ 32 and $ 37 on average for contracts for smaller offerings, meaning the price for the two doses would range from $ 64. and $ 74 per person.
According to the agency “Reuters”, the European Commission wants to reach an agreement with the company to supply millions of doses of the Corona vaccine, at a price lower than 25 dollars a dose.
Pfizer-Bionic vaccine: The alliance of the two companies announced that their vaccine has proven to be 90% effective in preventing infection by the virus, as long as the vaccine is kept at a temperature of minus 70 degrees Celsius.
20 million Americans are expected to be vaccinated with the vaccine next December and another 25 million next January, provided that the total doses to be provided through the end of 2021 reach around 1.3 billion doses.
The price of the advertised Pfizer vaccine ranges from $ 20 to $ 28, or $ 40 to $ 56 for the two doses.
Septonic vaccine in: The Sputnik-V vaccine is currently in a third phase of clinical trials, and the manufacturing company has confirmed that it is 92% effective, with the potential to produce 500 million doses each year.
Officials did not disclose the price, but independent experts estimated the price of 1.5 million doses of the vaccine agreed upon with a contractor to be $ 19.5 million, meaning the price of one dose of the Russian vaccine. it’s about $ 13.
And Russian President Vladimir Putin expected world sales of the Russian vaccine to reach $ 100 billion annually.
Crown Vacc: A Chinese official said that the annual production capacity of the Chinese “Corona Vaccine” vaccine is likely to reach 610 million doses by the end of this year.
And Beijing announced that the vaccine will be priced fairly and acceptably, and will support developing countries in that context through a number of means, such as donations and aid.
China has not announced the price of the vaccine, but the Chinese company “Sinopharm”, which produces the vaccine, said last August that the vaccine would cost no more than 1,000 yuan ($ 144.27) for the two doses.
While other estimates indicate that the dose may reach $ 88, but after the American companies Moderna and Pfizer announced lower prices for their vaccines, the price of the Chinese vaccine is expected to drop significantly.
Oxford and AstraZeneca: The University of Oxford in Britain and AstraZeneca are close to completing the third phase of their vaccine, the results of which are expected to be announced next month, according to Oxford officials.
The expected price of the Oxford vaccine is only about $ 4, which is the lowest compared to all other advertised vaccines.
AstraZeneca expects to manufacture 400 million doses in Britain and has contracted with an Indian company to produce 1 billion doses after the Oxford vaccine was licensed.
[ad_2]
